ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

Encap will collaborate with Lipocine to manufacture Lipcine's oral testosterone product, LPCN 1021, for Phase III clinical trials.

Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.

A collaborative pharmaceutical project to develop paediatric formulations using smart design and predictive science has received the go ahead after securing a ?660,000 grant from UK-based Technology Strategy Board.

Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.

Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.

FDA completes an inspection of Cambrex's API manufacturing facility in Charles City, Iowa.

Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.

CMC Biologics and OnoSynergy form an agreement from cell-line development.

Bristol-Myers Squibb agrees to sell global diabetes business to AstraZeneca for $2.7 billion upfront plus an addition $1.4 billion in potential regulatory- and sales-based milestone payments.

Pfizer appoints management changes to take effect in 2014.

Merck Serono, the biopharmaceutical division of Merck, has entered into an agreement on cancer drug development with the Spanish National Cancer Research Centre (CNIO) in Madrid.

AstraZeneca issues a statement regarding the launch of esomeprazole strontium in the United States.

FDA and EMA launch initiative to share bioequivalence inspection information.

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.

Bridgepoint Development Capital acquires Quotient for an undisclosed sum.

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.

Accelrys aquires Ireland-based Qumas, a provider of cloud-based and on-premises enterprise compliance software.

Merck's new facility for aseptic production in Reinbek, Germany is scheduled to be completed in 2016.

AstraZeneca's MedImmune will collaborate with Johns Hopkins University in both biologics and small-molecule projects.

Roche announces changes to its board of directors scheduled for March 4, 2014.

FDA has issued a proposed rule to require manufacturers of antibacterial hand soaps and body washes to demonstrate that their products are safe for long-term daily use and more effective than plain soap and water.

Agency issues precautionary recall due to manufacturing fault.

Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.

Agency issues precautionary recall due to manufacturing fault.

Charles River Laboratories makes organizational changes to improve the company's productivity initiatives.

Moberg Pharma will acquire three OTC brands from Bayer HealthCare.